Saurabhi Das

Saurabhi Das

Auto-generated profile, based on publicly available information

Saurabhi Das

Health City Hospital

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2013 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
PDF file
ARArjun Ravishankar
Arjun Ravishankar
Rajat ThawaniRajat Thawani
Rajat Thawani
PDPooja Dewan
Pooja Dewan
SDSaurabhi Das
Saurabhi Das
AKArchana Kashyap
Archana Kashyap
MFMoonis Mohammed Akbar Faridi
Moonis Mohammed Akbar Faridi

28 February 2025 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
MKMirza Mohd Kamran
Mirza Mohd Kamran
AGArun Gopi
Arun Gopi
SDSaurabhi Das
Saurabhi Das
ZLZeeshan Lakhani
Zeeshan Lakhani
ASAmira Sheikh
Amira Sheikh
MMMusthafa P.P. Mohammad
Musthafa P.P. Mohammad
Background: When anomalous left coronary artery from the pulmonary artery is diagnosed in infancy, it is associated with high mortality, but collaterals permit rare adult survival despite coronary steal. We report normalisation of perfusion abnormality after transcatheter proximal left coronary occlusion in a symptomatic adult with inducible ischaemia. Methods: A forty-eight-year-old female presented with exertional chest pain; EKG showed sinus rhythm with left axis deviation with intraventricular conduction defect. Echocardiogram diagnosed an anomalous left coronary artery arising from the pulmonary artery with normal ventricular function which was further confirmed by CT. The case was discussed with the surgical team, and it was decided to surgically ligate. The patient did not give consent for the surgical procedure; the patient was taken up for the procedure. Results: Device was released safely after confirming the position on echocardiogram after the procedure showed improvement in intraventricular conduction defect and QTc duration, and also no significant ischaemic changes were noted. Myocardial perfusion scintigraphy was done after 6 months of procedure which showed improvement in contractile function and perfusion of left ventricle. Conclusions: Device closure in long-standing anomalous left coronary artery from pulmonary artery case is safe, and long-term follow-up is needed.

22 January 2026 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
SDSaurabhi Das
Saurabhi Das
SJShantanu Jain
Shantanu Jain
MKMirza Mohd Kamran
Mirza Mohd Kamran
SPSukanya Pathak
Sukanya Pathak
KSKangkan Sharma
Kangkan Sharma
NSNarendra Sharma
Narendra Sharma
Background: Percutaneous device closure is the preferred method for closing patent ductus arteriosus (PDA), even in preterm infants. We report our experience using the new KONAR-MFO™ ventricular septal defect occluder for transcatheter closure of preterm patent ductus arteriosus as an alternative device in resource-limited centres. Methodology: Case 1: A preterm baby with Down’s syndrome and tracheobronchomalacia was born at 29 weeks, weighing 1.68 kg with multiple cardiac defects, including a 4 mm PDA and a 6 mm mid-muscular ventricular septal defect (VSD), stuck on a ventilator. Case 2: Another preterm baby born at 35 weeks, weighing 1.89 kg, with anorectal malformation and a right inguinal hernia. The echocardiogram revealed a 4 mm PDA with severe PAH. In both cases, the patent ductus arteriosus was occluded using a 6 mm × 4 mm Konar MFO device on day 14 (case 1) and day 20 (case 2). Results: The baby (case 1) was weaned off the ventilator and discharged on the 28th postnatal day at 2.09 kg. As for case 2, the baby was weaned off the ventilator within 2 days and discharged on day 30 at 2.23 kg. A follow-up echocardiogram of both cases confirmed a well-positioned device with no obstructions. At 18 months, in the follow-up, both babies were gaining weight and thriving. Conclusions: The KONAR MFO device is a safe and effective option for patent ductus arteriosus closure in preterm infants, even in resource-limited settings. Its versatility accommodates various duct sizes and morphologies, and its self-expandable design ensures easy deployment, addressing the anatomical challenges often seen in preterm infants.

9 February 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
SDSaurabhi Das
Saurabhi Das
SJShantanu Jain
Shantanu Jain
BackgroundAcute severe hemolysis following atrial septal defect (ASD) device closure is extremely rare, with precise incidence, underlying etiologies, and optimal management strategies remain inadequately understood.Case SummaryWe report a case of significant hemolysis after transcatheter ASD closure in 10 year old female, possibly related to the interface between the device surface and the high velocity jet of valvular regurgitation. Although many instances require device retrieval, in our case, hemolysis was conservatively managed with fluids, diuresis, corticosteroids and sodium bicarbonate and was discharged successfully on the 6th post-procedure day. In this case report, we aim to showcase the pathophysiology and management of acute severe hemolysis that occurred after ASD device closure.ConclusionBy sharing our clinical experience and discussing potential risk factors associated with this serious complication, we aspire to provide valuable insights that may reform future clinical practices and enhance preventive measures.

30 September 2026 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
SDSaurabhi Das
Saurabhi Das
SJShantanu Jain
Shantanu Jain
FAFaruk Abdullah
Faruk Abdullah
Acute severe haemolysis following atrial septal defect(ASD) device closure is extremely rare, where precise incidence, underlying aetiologies, and optimal management strategies remain inadequately understood. We report a case of significant haemolysis after transcatheter atrial septal defect closure in 10 year old female, possibly related to the interface between the device surface and the high-velocity jet of valvular regurgitation resulting from the abnormal configuration of the device. The presence of a residual shunt, combined with atrioventricular valve regurgitation flow, places pressure on the occluder’s discs, leading to increased erythrocyte fragility and subsequent rupture. In our case, haemolysis was initially conservatively managed with fluids, diuresis, and sodium bicarbonate, and the patient was discharged successfully on the 6 th post-procedure day. Surgical retrieval was advised; however, the patient was subsequently lost to follow-up. In this case report, we aim to showcase the pathophysiology, technical pitfalls regarding the procedure and management of acute severe haemolysis that occurred after atrial septal defect device closure. In conclusion, by sharing our clinical experiences and addressing misconceptions and potential risk factors for this serious complication, we aim to provide insights that may enhance future clinical practice and preventive strategies.